Science Explorer Back to mapMap

Most cited papers from Avid Bioservices (United States)

What are the most cited papers from Avid Bioservices (United States)?

The most cited paper from Avid Bioservices (United States) is "Phosphatidylserine is a global immunosuppressive signal in efferocytosis, infectious disease, and cancer" (Raymond B. Birge, Sebastian Boeltz, Sushil Kumar et al., 2016), with 762 citations. Next come "Targeting inside-out phosphatidylserine as a therapeutic strategy for viral diseases" (199) and "Safety and Feasibility of Convection-enhanced Delivery of Cotara for the Treatment of Malignant Glioma: Initial Experience in 51 Patients" (167).

Showing 50 of 58 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Phosphatidylserine is a global immunosuppressive signal in efferocytosis, infectious disease, and cancer Raymond B. Birge, Sebastian Boeltz, Sushil Kumar et al. · Cell Death and Differentiation Open access 26 Feb 2016 762
2 Targeting inside-out phosphatidylserine as a therapeutic strategy for viral diseases Melina Soares, Steven W. King, Philip E. Thorpe · Nature Medicine Open access 23 Nov 2008 199
3 Safety and Feasibility of Convection-enhanced Delivery of Cotara for the Treatment of Malignant Glioma: Initial Experience in 51 Patients Sunil J. Patel, William R. Shapiro, Douglas W. Laske et al. · Neurosurgery 30 May 2005 167
4 Beyond the walls of the nucleus: the role of histones in cellular signaling and innate immunityThis paper is one of a selection of papers published in this Special Issue, entitled 27th International West Coast Chromatin and Chromosome Conference, and has undergone the Journal's usual peer review process. Missag Hagop Parseghian, Keith A. Luhrs · Biochemistry and Cell Biology Aug 2006 162
5 Formation, Clearance, Deposition, Pathogenicity, and Identification of Biopharmaceutical-related Immune Complexes Jennifer L. Rojko, Mark Gordon Evans, Shari A. Price et al. · Toxicologic Pathology 3 Apr 2014 150
6 Rapid H1 linker histone transitions following fertilization or somatic cell nuclear transfer: evidence for a uniform developmental program in mice Shaorong Gao, Young Gie Chung, Missag Hagop Parseghian et al. · Developmental Biology Open access 24 Nov 2003 138
7 Phosphatidylserine Sensing by TAM Receptors Regulates AKT-Dependent Chemoresistance and PD-L1 Expression Canan Kasikara, Sushil Kumar, Stanley Gititu Kimani et al. · Molecular Cancer Research Open access 9 Feb 2017 129
8 A compendium of the histone H1 family of somatic subtypes: An elusive cast of characters and their characteristics Missag Hagop Parseghian, Barbara A. Hamkalo · Biochemistry and Cell Biology Jun 2001 123
9 Safety and Immunogenicity of LC16m8, an Attenuated Smallpox Vaccine in Vaccinia-Naive Adults Jeffrey S. Kennedy, Marc Gurwith, C. L. Dekker et al. · The Journal of Infectious Diseases Open access 15 Sep 2011 107
10 24-Hour IOP control with once-daily bimatoprost, timolol gel-forming solution, or latanoprost: a 1-month, randomized, comparative clinical trial Thomas R. Walters, Harvey B. Dubiner, Susan P. Carpenter et al. · Survey of Ophthalmology 27 Jan 2004 107
11 Chromatin Condensing Functions of the Linker Histone C-Terminal Domain Are Mediated by Specific Amino Acid Composition and Intrinsic Protein Disorder Xu Lu, Barbara A. Hamkalo, Missag Hagop Parseghian et al. · Biochemistry Open access 15 Dec 2008 104
12 Phosphatidylserine-targeting antibodies augment the anti-tumorigenic activity of anti-PD-1 therapy by enhancing immune activation and downregulating pro-oncogenic factors induced by T-cell checkpoint inhibition in murine triple-negative breast cancers Michael Jeffrey Gray, Jian Kun Gong, Michaela M. S. Hatch et al. · Breast Cancer Research Open access 11 May 2016 77
13 The Histone H1 C-Terminal Domain Binds to the Apoptotic Nuclease, DNA Fragmentation Factor (DFF40/CAD) and Stimulates DNA Cleavage Piotr Widlak, Magdalena Kalinowska, Missag Hagop Parseghian et al. · Biochemistry May 2005 62
14 Anti-phospholipid human monoclonal antibodies inhibit CCR5-tropic HIV-1 and induce β-chemokines M. Anthony Moody et al. · The Journal of Experimental Medicine Open access 5 Apr 2010 56
15 Characterization of a Phage Display-Derived Human Monoclonal Antibody (NHS76) Counterpart to Chimeric TNT-1 Directed Against Necrotic Regions of Solid Tumors Janhangir Sharifi, Leslie A. Khawli, Peisheng Hu et al. · Hybridoma and Hybridomics Oct 2001 53
16 131I-chTNT-1/B mAb: tumour necrosis therapy for malignant astrocytic glioma William R. Shapiro, Susan P. Carpenter, Karen C. Roberts et al. · Expert Opinion on Biological Therapy 13 Apr 2006 51
17 Antibody targeting of phosphatidylserine for the detection and immunotherapy of cancer Olivier Belzile, Xianming Huang, Jian Kun Gong et al. · ImmunoTargets and Therapy Open access 2018 49
18 A phase I clinical trial of bavituximab and paclitaxel in patients with HER2 negative metastatic breast cancer Pavani Chalasani, Marilyn Marron, Denise J. Roe et al. · Cancer Medicine Open access 31 Mar 2015 45
19 Elucidating variations in the nucleotide sequence of Ebola virus associated with increasing pathogenicity Stuart Dowall, David A. Matthews, Isabel García-Dorival et al. · Genome biology Open access 22 Nov 2014 44
20 Randomized phase III study of docetaxel plus bavituximab in previously treated advanced non-squamous non-small-cell lung cancer David E. Gerber et al. · Annals of Oncology Open access 8 May 2018 43
21 r84, a Novel Therapeutic Antibody against Mouse and Human VEGF with Potent Anti-Tumor Activity and Limited Toxicity Induction Laura A. Sullivan, Juliet G. Carbon, Christina Lynn Roland et al. · PLoS ONE Open access 6 Aug 2010 43
22 Bavituximab plus paclitaxel and carboplatin for the treatment of advanced non-small-cell lung cancer Raghunadharao Digumarti, Poonamalle Parthasarathy Bapsy, Attili Venkatasatya Suresh et al. · Lung Cancer 24 Aug 2014 41
23 Comparison of electronic brachytherapy and Mohs micrographic surgery for the treatment of early-stage non-melanoma skin cancer: a matched pair cohort study Rakesh P. Patel, Robert Strimling, Stephen W. Doggett et al. · Journal of Contemporary Brachytherapy Open access 2017 37
24 Phase I Study of 131 I-Chimeric(ch) TNT-1/B Monoclonal Antibody for the Treatment of Advanced Colon Cancer Hilary Hardy Street, Michael L. Goris, George Albert Fisher et al. · Cancer Biotherapy and Radiopharmaceuticals Jun 2006 32
25 Evicting hitchhiker antigens from purified antibodies Keith A. Luhrs, Debra A. Harris, Scott Summers et al. · Journal of Chromatography B 2 Apr 2009 29
26 Chromatographic behavior of IgM:DNA complexes Pete Gagnon, Frank Hensel, Soon Lee et al. · Journal of Chromatography A 24 Dec 2010 29
27 Docetaxel Combined With Bavituximab in Previously Treated, Advanced Nonsquamous Non–Small-Cell Lung Cancer David E. Gerber, David Robert Spigel, David Giorgadze et al. · Clinical Lung Cancer Open access 20 Feb 2016 23
28 Antibody-Mediated Phosphatidylserine Blockade Enhances the Antitumor Responses to CTLA-4 and PD-1 Antibodies in Melanoma Bruce D. Freimark, Jian Kun Gong, Dan Ye et al. · Cancer Immunology Research Open access 4 Apr 2016 23
29 Incorporation of Electronic Brachytherapy for Skin Cancer into a Community Dermatology Practice. Stephen W. Doggett, Mark Willoughby, Cole Willoughby et al. · PubMed Open access Nov 2015 20
30 Effective Binding of a Phosphatidylserine-Targeting Antibody to Ebola Virus Infected Cells and Purified Virions Stuart Dowall, Victoria Graham, Kara A. Corbin-Lickfett et al. · Journal of Immunology Research Open access 2015 18
31 The effects of hitchhiker antigens co-eluting with affinity-purified research antibodies Lilly Mechetner, Radhika Sood, Van Nguyen et al. · Journal of Chromatography B 24 Jul 2011 18
32 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two Casey R. Ager et al. · Journal for ImmunoTherapy of Cancer Open access1,802 authors Nov 2016 17
33 Phase Ib Study of Bavituximab With Carboplatin and Pemetrexed in Chemotherapy-Naive Advanced Nonsquamous Non–Small-Cell Lung Cancer Juneko E. Grilley‐Olson, Jared Weiss, Anastasia Ivanova et al. · Clinical Lung Cancer 16 Mar 2018 15
34 First-in-Man Evaluation of 124 I-PGN650: A PET Tracer for Detecting Phosphatidylserine as a Biomarker of the Solid Tumor Microenvironment Richard A. Laforest, Farrokh Dehdashti, Yongjian Liu et al. · Molecular Imaging Open access 2017 15
35 Catheterized guinea pigs infected with Ebola Zaire virus allows safer sequential sampling to determine the pharmacokinetic profile of a phosphatidylserine-targeting monoclonal antibody Stuart Dowall, Irene Taylor, Paul Yeates et al. · Antiviral Research 16 Nov 2012 14
36 High efficacy vasopermeability drug candidates identified by screening in an ex ovo chorioallantoic membrane model Desmond Pink, Keith A. Luhrs, Longen Zhou et al. · Scientific Reports Open access 29 Oct 2015 10
37 Measuring Response to Therapy by Near-Infrared Imaging of Tumors Using a Phosphatidylserine-Targeting Antibody Fragment Jian Kun Gong, Richard K. Archer, Michael D. Brown et al. · Molecular Imaging Open access Jun 2013 9
38 Multidisciplinary Locoregional Management of Breast Cancer Benjamin D. Smith, Elizabeth Ann Mittendorf, Bruce George Haffty · Journal of Clinical Oncology Open access 22 May 2020 8
39 In-Line Radiolabeling: A Novel Continuous-Flow System for Commercial-Scale Protein Labeling Debra A. Harris, Raimo Pellikka, Olga Gasser et al. · Journal of Nuclear Medicine Open access 12 Jun 2009 7
40 Dissociation and fractionation of heavy and light chains from IgG monoclonal antibodies Pete Gagnon, George Rodriquez, Simin Zaidi · Journal of Chromatography A 14 Dec 2010 6
41 Final clinical results from SUNRISE: A phase III, randomized, double-blind, placebo-controlled multicenter trial of bavituximab plus docetaxel in patients with previously treated stage IIIb/IV nonsquamous non-small cell lung cancer Ramón Palmero, Paolo Bidoli, Igor Bondarenko et al. · Annals of Oncology Open access Sep 2017 5
42 Toxicity and biodistribution of an iodine‐131‐radiolabelled tumour necrosis‐targeting antibody in non‐tumour‐bearing domestic felines D. M. Van Walleghen, Missag Hagop Parseghian · Veterinary and Comparative Oncology Mar 2006 5
43 Top-line results from SUNRISE: A phase III, randomized, double-blind, placebo-controlled multicenter trial of bavituximab plus docetaxel in patients with previously treated stage IIIb/iv non-squamous non-small cell lung cancer David Robert Spigel, Igor Bondarenko, György Losonczy et al. · Annals of Oncology Open access Oct 2016 3
44 Electronic brachytherapy management of atypical fibroxanthoma: report of 8 lesions Stephen W. Doggett, James Brazil, Markéta Lı́mová et al. · Journal of Contemporary Brachytherapy Open access 2017 3
45 In vivohistone H1 migration from necrotic to viable tissue Keith A. Luhrs, Desmond Pink, Wendy Schulte et al. · Oncotarget Open access 7 Feb 2017 3
46 Clinical Update: Treatment of Glioblastoma Multiforme with Radiolabeled Antibodies that Target Tumor Necrosis Randy L. Jensen, Joseph S. Shan, Bruce Freimark et al. · Current Cancer Therapy Reviews Feb 2010 2
47 Anti-Tumor Responses By Ibrutinib and Anti-PD-1 Blockade Is Enhanced By Phosphatidylserine-Targeting Antibody Therapy Jian Kun Gong, Michael Jeffrey Gray, Jeff T. Hutchins et al. · Blood 2 Dec 2016 1
48 Antibody mediated blockade of phosphatidylserine improves immune checkpoint blockade by repolarizing immune suppressive mechanisms of the tumor microenvironment J. Hutchins · Annals of Oncology Open access Oct 2016 1
49 Dosimetry of phase I interstitial 131I-chTNT-1/B MAb (Cotara) for the treatment of recurrent glioma Sui Shen, R. A. Lustig, Kevin D Judy et al. · Journal of Nuclear Medicine May 2009 1
50 Antibody targeting of phosphatidylserine produces a cytokine microenvironment that enhances innate anti-tumor immune responses Monica L. Friedrich, Claudia I. Guevara, Daniel M. Falcon et al. · Cancer Research May 2008 0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.